Vol 2023, No 3 (2023)

Table of Contents

Research & Development

Merck Signs US$922.5 M Collaboration with OPKO Health for Epstein-Barr Virus Vaccine Abstract pdf html
Lalit Mishra & Lucy Haggerty
BioNTech Collaborates with OncoC4 to Co-Develop CTLA-4 Cancer Antibody Abstract pdf html
Ayush Saxena
UCB Enters into Drug Discovery Collaboration with Aitia for Huntington’s Disease Abstract pdf html
Ashish Tripathi

Licensing

Eli Lilly Licenses Non-Opioid Pain Drug from Confo Therapeutics Abstract pdf html
Lucy Haggerty
ImmunoGen Signs Partnership with Vertex for Conditioning Agents worth US$352 M Abstract pdf html
Swati Sharan

Mergers & Acquisitions

Pfizer to Acquire ADC Cancer Specialist Seagen for US$43 B Abstract pdf html
Lucy Haggerty
Sanofi Buys Provention Bio and its Type 1 Diabetes Drug for US$2.9 B Abstract pdf html
Lucy Haggerty
Adaptimmune and TCR2 Merge to Form a Solid Tumour Company Abstract pdf html
Shweta Gupta & Lucy Haggerty

Opinion & Analysis

IQVIA Pharma Deals Review of 2022 Abstract pdf
Heather Cartwright, Taskin Ahmed & Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.